20.12.2019 • NewsDede WillamsDuPontChemours

Court Hears DuPont-Chemours Dispute Arguments

Court Hears DuPont-Chemours Dispute Arguments
Court Hears DuPont-Chemours Dispute Arguments

A Delaware court this week began hearing a dispute between DuPont and its former chemicals business Chemours over liabilities for payouts connected to spills of fluorochemicals into US waterways.

DuPont is asking the court to dismiss a lawsuit from the company spun off in 2015 that claims it massively downplayed the cost of environmental liabilities Chemours would face after separation from the former parent.

Both companies are based in Wilmington, Delaware. DuPont says the lawsuit must be dismissed because the separation agreement mandates that disputes arising from the 2015 spinoff must be resolved through private arbitration.

DuPont also rejects Chemours’ allegation that it deliberately spun off the business to shift hundreds of millions of dollars in environmental liabilities to it.

At the time of the spinoff, prior to DuPont’s merger into DowDuPont – from which it emerged earlier this year – the then-broadly focused chemical producer was facing multidistrict litigation involving 3,500 personal injury claims related to the fluorochemical PFOA, used in production of the Teflon-branded non-stick coating.

Chemours’ lawyers want the judges to declare that the company is not responsible for liabilities exceeding the maximums certified by DuPont or any of its historical liabilities exceeding the cap. Alternatively, it is asking that the $3.9 billion dividend it paid DuPont at the time separation be returned.

Artificial Intelligence

Pierre Racz: "Real Artificial Intelligence Does Not Exist"
part one of a three-part interview series

Pierre Racz: "Real Artificial Intelligence Does Not Exist"

In part one Pierre Racz, President of Genetec, is addressing why IP network video systems were the game changer in the industry and why he does not like the term AI.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

most read

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
15.01.2025 • News

Global Outlook on Bio-based Polymers

It is important to examine the current state of bio-based polymers. This includes the rapidly growing production capacity, significant investments currently underway in China, Europe, and the Middle East, and the new political conditions in Europe that are driving demand for biodegradable polymers.

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.

Photo
27.03.2025 • News

Moeve Joins Global Impact Coalition

The Global Impact Coalition (GIC), a collaborative platform led by CEOs and focused on achieving a net-zero chemicals future, has announced the addition of Moeve as its newest member.